RUPATADINE Oral solution Ref.[7356] Active ingredients: Rupatadine

Source: Medicines & Healthcare Products Regulatory Agency (GB)  Revision Year: 2018  Publisher: J. Uriach y Compaรฑia, S.A., Av. Camรญ Reial, 51-57, 08184 Palau-solitร  i Plegamans (Spain), Telephone: +34 93 864 96 92, Fax: +34 93 864 66 06

Therapeutic indications

Rupafin 1 mg/ml oral solution is indicated for the symptomatic treatment of:

  • Allergic rhinitis (including persistent allergic rhinitis) in children aged 2 to 11 years (see section 5.1).
  • Urticaria in children aged 2 to 11 years (see section 5.1).

Posology and method of administration

Children aged 2 to 11 years.

Dosage in children weighing equal or more than 25 kg: 5 ml (5 mg of rupatadine) of oral solution once a day, with or without food.

Dosage in children weighing equal or more than 10 kg up to less than 25 kg: 2.5 ml (2.5 mg of rupatadine) of oral solution once a day, with or without food.

The administration of the product to children aged under 2 years is not recommended due to the lack of data in this population (see section 4.4).

In adults and adolescents (over 12 years of age), the administration of rupatadine 10 mg tablets is more appropriate.

Patients with renal or hepatic insufficiency: As there is no clinical experience in patients with impaired kidney or liver functions, the use of rupatadine is at present not recommended in these patients.

Instructions of use:

  • To open the bottle press the cap and turn it anticlockwise.
  • Take the syringe and put it in the perforated stopper and turn the bottle upside down.
  • Fill the syringe with the prescribed dose.
  • Administer directly from the dosing syringe.
  • Wash the syringe after use.

Overdose

No case of overdose has been reported in adults and children. In a clinical safety study in adults rupatadine at daily dose of 100 mg during 6 days was well tolerated. The most common adverse reaction was somnolence. If accidental ingestion of very high doses occurs symptomatic treatment together with the required supportive measures should be given.

Shelf life

Shelf life: 30 months.

The shelf life after first opening is the same as the expiry date placed on the box and the bottle.

Special precautions for storage

This medicinal product does not require any special storage conditions.

Nature and contents of container

120 ml amber polyethylene terephthalate (PET) bottle with low density polyethylene (LDPE) perforated stopper closed with yellow high density polyethylene (HDPE) child-resistant closure in a cardboard box also containing 5 ml oral syringe (polypropylene, polyethylene) graduated at 0.25 ml.

Special precautions for disposal and other handling

No special requirements.

Any unused product or waste material should be disposed of in accordance with local requirements.

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.